Advertisement

Inflammation

, Volume 29, Issue 2–3, pp 65–71 | Cite as

Relationship of Five Inflammatory Gene Polymorphisms with Morbidity and Mortality in 533 Patients Admitted to an ICU

  • Jan R. Ortlepp
  • Jürgen Graf
  • Katharina Vesper
  • Fabian Schmitz
  • Vera Mevissen
  • Sebastian Sucigan
  • Alexander Kersten
  • Christian Weber
  • Uwe Janssens
Article
  • 58 Downloads

Abstract

Background

The aim of this study was to analyze the association of polymorphisms of five candidate genes with the outcome of consecutive patients admitted to a medical ICU.

Materials and Methods

The study population was prospectively recruited. Inclusion criteria were admission to the ICU and written informed consent by the patients or their relatives. A total of 533 patients were recruited. The morbidity was assessed by SAPS II Score. Outcome data of in hospital mortality and length of ICU and hospital stay were obtained. Genotyping for genetic polymorphisms (CRP 1059, IL1B −511, CTGF −477, CCR2 64VI, IL6 −174) were performed by allele-specific fluorogenic oligonucleotide probes (TaqMan analysis).

Results

All of the investigated polymorphisms were not associated with an altered outcome. There was no difference in morbidity and ICU or in-hospital mortality (neither in cross tabs analysis nor in Kaplan Meier or Cox regression analysis including age, gender and diagnosis as covariates) between the different genotypes.

Conclusions

Genotyping of the investigated polymorphism for risk stratification of patients admitted to ICU does not seem to be appropriated.

Key words

genetic polymorphism ICU mortality morbidity 

Notes

Acknowledgment

This study was supported by the START program of the University Hospital of Aachen and is part of the doctoral thesis of Katharina Vesper.

References

  1. 1.
    Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801–809.PubMedCrossRefGoogle Scholar
  2. 2.
    Alexander, R. W. 1994. Inflammation and coronary artery disease. N. Engl. J. Med. 331:468–469.PubMedCrossRefGoogle Scholar
  3. 3.
    Ridker, P. M. 2001. Role of inflammatory biomarkers in prediction of coronary heart disease. Lancet 358:946–948.PubMedCrossRefGoogle Scholar
  4. 4.
    Mehta, J. L., T. G. P, Saldeen, and K. Rand. 1998. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J. Am. Coll. Cardiol. 31:1217–1225.PubMedCrossRefGoogle Scholar
  5. 5.
    Rupprecht, H. J., S. Blankenberg, C. Bickel, G. Rippin, G. Hafner, W. Prellwitz, W. Schlumberger, and J. Meyer. 2001. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 104:25–31.PubMedGoogle Scholar
  6. 6.
    Mira, J. P., A. Cariou, F. Grall, C. Delclaux, M. R. Losser, F. Heshmati, C. Cheval, M. Monchi, J. L. Teboul, F. Riche, G. Leleu, L. Arbibe, A. Mignon, M. Delpech, and J. F. Dhainaut. 1999. Association of TNF2, a TNF-alpha promotor polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561–568.PubMedCrossRefGoogle Scholar
  7. 7.
    Tang, G. J., S. L. Huang, H. W. Yien, W. S. Chen, C. W. Chi, C. W. Wu, W. Y. Lui, J. H. Chiu, and T. Y. Lee. 2000. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit. Care. Med. 28:2733–2736.PubMedCrossRefGoogle Scholar
  8. 8.
    Yende, S., M. W. Quasney, E. Tolley, Q. Zhang, and R. G. Wunderink. 2003. Association of tumor necrosis factor gene polymorphism and prolonged mechanical ventilation after coronary artery bypass surgery. Crit. Care. Med. 31:133–140.PubMedCrossRefGoogle Scholar
  9. 9.
    Ohnishi, H., T. Oka, S. Kusachi, T. Nakanishi, K. Takeda, M. Nakahama, M. Doi, T. Murakami, Y. Ninomiya, M. Takigawa, and T. Tsuji. 1998. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J. Mol. Cell Cardiol. 30:2411–2422.PubMedCrossRefGoogle Scholar
  10. 10.
    Blom, I. E., A. J. van Dijk, R. A. de Weger, M. G. J. Tilanus, and R.Goldschmeding. 2001. Identification of human ccn2* (connective tissue growth factor) promoter polymorphism. J. Clin. Pathol.: Mol. Pathol. 54:192–196.CrossRefGoogle Scholar
  11. 11.
    Abdi, R., T. T. B. Huong, A. Shagun-Ruiz, P. M. Murphy, B. M. Brenner, E. L. Milford, and D. H. McDermott. 2002. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J. Am. Soc. Nephrol. 13:754–758.PubMedGoogle Scholar
  12. 12.
    Ortlepp, J. R., K. Vesper, V. Mevissen, F. Schmitz, U. Janssens, A. Franke, P. Hanrath, C. Weber, K. Zerres, and R. Hoffmann. 2003. Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age. J. Mol. Med. 81:363–367.PubMedCrossRefGoogle Scholar
  13. 13.
    Ridker, P. M., R. J. Glynn, and C. H. Hennekens. 1998. C-reactive Protein adds to predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97:2007–2011.PubMedGoogle Scholar
  14. 14.
    Cao, H., and R. A. Hegele. 2000. Human C-reactive protein (CRP) 1059 G/C polymorphism. J. Hum. Genet. 45:100–101.PubMedCrossRefGoogle Scholar
  15. 15.
    Zee, R. Y. L., and P. M. Ridker. 2002. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162:217–219.PubMedCrossRefGoogle Scholar
  16. 16.
    Read, R. C., N. J. Camp, F. S. diGiovine, R. Borrow, E. B. Kaczmarski, A. G. A. Chaudhary, J. F. Andrew, and G. W. Duff. 2000. An Interleukin-1 genotype is associated with fatal outcome of menigococcal disease. J. Infect. Dis. 182:1557–1560.PubMedCrossRefGoogle Scholar
  17. 17.
    Ma, P., D. Chen, J. Pan, and B. Du. 2002. Genomic polymorphism within interleukin-1 family cytokines influence the outcome of septic patients. Crit. Care Med. 30:1046–1050.PubMedCrossRefGoogle Scholar
  18. 18.
    Brull, D. J., H. E. Montgomery, J. Sanders, S. Dhamrait, L. Luong, A. Rumley, G. D. Lowe, and S. E. Humphries. 2001. Interleukin-6 gene 174G>C and 572G>C promoter polymorphism are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler. Thromb. Vasc. Biol. 21:1458–1463.PubMedGoogle Scholar
  19. 19.
    Ortlepp, J. R., J. Metrikat, K. Vesper, V. Mevissen, F. Schmitz, M. Albrecht, P. Maya-Pelzer, P. Hanrath, K. Zerres, and R. Hoffmann. 2003. The interleukin 6 promotor polymorphism is associated with elevated leukocytes and reduced physical fitness in young healthy smokers. J. Mol. Med. 81:578–584.PubMedCrossRefGoogle Scholar
  20. 20.
    Le Gall, J. R., S. Lemeshow, and F. Saulnier. 1993. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963.PubMedCrossRefGoogle Scholar
  21. 21.
    Schlüter, B., C. Raufhake, M. Erren, H. Schotte, F. Kipp, S. Rust, H. VanAken, G. Assmann, and E. Berendes. 2002. Effect of the interleukin-6 promotor polymorphism (174 G/C) on the incidence and outcome of sepsis. Crit. Care. Med. 30:32–37.PubMedCrossRefGoogle Scholar
  22. 22.
    Burzetta, F., L. Iacoviello, A. DiCastenuovo, F. Glieca, N. Luciani, R. Zamparelli, R. Schiavello, M. B. Donati, A. Maseri, G. F. Possati, and F. Andreotti. 2001. Relation of the 174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am. J. Cardiol. 88:1125–1128.CrossRefGoogle Scholar
  23. 23.
    D'Aiuto, F., J. P. Casas, T. Shab, S. E. Humphries, A. D. Hingorani, and M. S. Tonetti. 2005. C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 179:413–417.PubMedCrossRefGoogle Scholar
  24. 24.
    Eklund, C., F. Jahan, T. Pessi, T. Lehtimaki, and M. Hurme. 2003. Interleukin 1B gene polymorphism is associated with baseline C-reactive protein levels in healthy individuals. Eur. Cytokine Netw. 14:168–171.PubMedGoogle Scholar
  25. 25.
    Lee, S. H., C. G. Ihm, S. D. Sohn, T. W. Lee, M. J. Kim, G. Koh, S. J. Oh, J. T. Woo, S. W. Kim, J. W. Kim, Y. S. Kim, B. C. Lee, S. D. Kim, B. S. Cho, H. J. Lee, and J. H. Chung. 2004. Polymorphisms in interleukin-1 beta and Interleukin-1 receptor antagonist genes are associated with kidney failure in Korean patients with type 2 diabetes mellitus. Am. J. Nephrol. 24:410–414.PubMedCrossRefGoogle Scholar
  26. 26.
    Halverstadt, A., D. A. Phares, S. Roth, R. E. Ferrell, A. P. Goldberg, and J. M. Hagberg. 2005. Interleukin-6 genotype is associated with high-density lipoprotein cholesterol responses to exercise training. Biochim. Biophys. Acta 1734:143–151.PubMedGoogle Scholar
  27. 27.
    Vozarova, B., J. M. Fernandez-Real, W. C. Knowler, L. Gallart, R. L. Hanson, J. D. Gruber, W. Ricart, J. Vendrell, C. Richart, P. A. Tataranni, and J. K. Wolford. 2003. The interleukin-6 (−174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum. Genet. 112:409–413.PubMedGoogle Scholar
  28. 28.
    Rundek, T., M. S. Elkind, J. Pittman, B. Boden-Albala, S. Martin, S. E. Humphries, S. H. Juo, and R. L. Sacco. 2002. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 33:1420–1423.PubMedCrossRefGoogle Scholar
  29. 29.
    Aegerter, P., A. Boumendil, A. Retbi, E. Minvielle, B. Dervaux, and B. Guidet. 2005. SAPS II revisited. Intensive Care Med. 31:416–423.PubMedCrossRefGoogle Scholar
  30. 30.
    Editorial. 1999. Freely association. Nat. Genet. 22:1–2.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Jan R. Ortlepp
    • 1
    • 2
  • Jürgen Graf
    • 2
  • Katharina Vesper
    • 2
  • Fabian Schmitz
    • 2
  • Vera Mevissen
    • 2
  • Sebastian Sucigan
    • 2
  • Alexander Kersten
    • 2
  • Christian Weber
    • 2
  • Uwe Janssens
    • 3
  1. 1.Interdisciplinary Intermediate CareUniversity Hospital of Aachen-RTWTHAachenGermany
  2. 2.Medical Clinic IUniversity Hospital of Aachen Hospital of Aachen-RTWTHAachenGermany
  3. 3.St Antonius HospitalEschweilerGermany

Personalised recommendations